Databricks, the leader in data and AI, has announced its intent to acquire Neon, the serverless Postgres platform powering AI agent workloads. This strategic move signals Databricks’ commitment to redefining the future of databases to meet the evolving demands of AI-native and developer-first environments.
Adopt AI, an Agentic AI company, has officially launched its groundbreaking platform that allows applications to deliver intelligent, conversational agent experiences. Backed by a $6 million seed round led by Elevation Capital, the company aims to eliminate clunky workflows and usher in a new era of human-like software interaction powered by natural language.
As generative AI gains widespread enterprise adoption, the challenge of maintaining strong, consistent data governance and security has never been more urgent. Addressing this gap head-on, Theom—the first AI-native Data Operations Center (DOC) platform—has announced a $20 million Series A funding round. Led by Wing VC with support from SentinelOne, Snowflake, and Databricks, this investment propels Theom’s mission to secure sensitive data across cloud, SaaS, and AI ecosystems.
Techman Robot, a global leader in AI-powered collaborative robotics, is celebrating its 10th anniversary by showcasing cutting-edge automation innovations at Automate 2025. The company’s booth will feature a variety of AI-driven real-world applications, including high-speed flying-trigger inspection, semiconductor wafer box handling, intelligent welding, and the highly anticipated debut of the lightweight, long-reach cobot, TM6S. These innovations demonstrate Techman Robot’s leadership in smart manufacturing solutions across various industries.
MikeWorldWide (MWW) has unveiled its groundbreaking platform, PRISMA Labs.ai, a fusion of public relations (PR), artificial intelligence (AI), and strategic marketing intelligence designed to bring clarity to complexity and power communications that drive results. With an initial focus on building and protecting brand reputation in the AI-driven world, PRISMA Labs.ai represents MWW’s commitment to advancing the intersection of communication and technology.
Trinity Education Group is revolutionizing the evaluation of K-12 instructional materials with the launch of EVA (Evaluation Assistant), an AI-powered platform set to launch on June 1, 2025. EVA enhances the review process for textbooks, teacher guides, and supplemental materials by providing state education agencies and publishers with unprecedented precision, efficiency, and depth in evaluating curriculum alignment and quality. In response to the increasing demand for high-quality, standards-aligned instructional materials (HQIM), EVA delivers an innovative, AI-driven solution to streamline and improve the traditional evaluation process. Combining advanced artificial intelligence and machine learning tools, EVA offers comprehensive content analysis tailored specifically to education needs.
Artera, a leading developer of multimodal artificial intelligence (MMAI)-based predictive tools for cancer, announced the publication of a validation study in the JCO Clinical Cancer Informatics. The study examined the ability of Artera’s MMAI model to predict prostate cancer outcomes across diverse racial groups, including African American patients. This comes at a critical time, as AI tools in healthcare face scrutiny for potentially exacerbating racial biases, particularly when they are trained on non-representative datasets.
Hikvision has officially launched its groundbreaking Guanlan AI models, designed to enhance the capabilities of AI-powered Internet of Things (AIoT). These large-scale, pre-trained machine learning engines excel in computer vision, natural language processing (NLP), and multimodal image fusion, setting a new standard in smart digital transformation across industries.
In a bold step forward, MaxisIT has rebranded as Maxis AI and launched its flagship Agentic AI Platform, marking a new era in clinical development. With the guiding principle “Designed to Think. Built to Act.”, the company is shifting from passive AI assistants to domain-aware agents capable of executing complex clinical trial tasks. The transformation promises faster insights, streamlined processes, and reduced costs for pharmaceutical and life sciences organizations.
